Development of cataract and associated risk factors: The Visual Impairment Project

Archives of Ophthalmology

Volumn 124, Issue 1, 2006, Pages 79-85

  Mukesh, Bickol N ^a,b   Le, Anhchuong ^b   Dimitrov, Peter N ^b   Ahmed, Shazia ^b   Taylor, Hugh R ^b   McCarty, Catherine A ^a  

^a MARSHFIELD CLINIC   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT;

ADULT; AGED; AGING; ARTHRITIS; ARTICLE; AUSTRALIA; CATARACT; CIGARETTE SMOKING; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DIET; FEMALE; FOLLOW UP; HUMAN; INTERVIEW; MALE; MYOPIA; NEW ZEALAND; PHOTOGRAPHY; PRIORITY JOURNAL; RANDOMIZATION; RISK FACTOR; SEX DIFFERENCE; STATISTICAL ANALYSIS; URBAN AREA;

ADULT; AGED; AGED, 80 AND OVER; AGING; CATARACT; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS; SEX DISTRIBUTION; URBAN POPULATION; VICTORIA; VISUALLY IMPAIRED PERSONS;

EID: 30344437561     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.124.1.79     Document Type: Article

References (67)

1. West SK. Looking forward to 20/20: a focus on the epidemiology of eye diseases. Epidemiol Rev.2000;22:64-70.
2. Keeffe JE, Taylor HR. Cataract surgery in Australia 1985-94. Aust N Z J Ophthalmol. 1996;24:313-317.
3. Brian G, Taylor HR. Cataract blindness: challenge for the 21st century. Bull World Health Organ.2001;79:249-256.
4. Leske MC, Wu SY, Nemesure B, Hennis A. Risk factors for incident nuclear opacities. Ophthalmology.2002;109:1303-1308.
5. Schaumberg DA, Glynn RJ, Christen WG, et al. A prospective study of blood pressure and risk of cataract in men. Ann Epidemiol.2001;11:104-110.
6. Schaumberg DA, Glynn RJ, Christen WG, et al. Relations of body fat distribution and height with cataract in men. Am J Clin Nutr.2000;72:1495-1502.
7. Klein BEK, Klein R, Lee KE. Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the Beaver Dam Eye Study. Am J Ophthalmol. 1998;126:782-790.
8. Klein BEK, Klein R, Lee KE. Reproductive exposures, incident age-related cataracts, and age-related maculopathy in women: the Beaver Dam Eye Study. Am J Ophthalmol.2000;130:322-326.
9. Wong TY, Klein BEK, Klein R, et al. Refractive errors and incident cataracts: the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci.2001;42:1449- 1454.
10. Mares-Perlman JA, Lyle BJ, Klein R, et al. Vitamin supplement use and incident cataracts in a population-based study. Arch Ophthalmol.2000;118:1556- 1563.
11. Klein BEK, Klein R, Lee KE. Incident cataract after a five-year interval and lifestyle factors: the Beaver Dam Eye Study. Ophthalmic Epidemiol.1999;6: 247-255.
12. McCarty CA, Mukesh BN, Fu CL, Taylor HR. The epidemiology of cataract in Australia. Am J Ophthalmol.1999;128:446-465.
13. West SK, Valmadrid CT. Epidemiology of risk factors for age-related cataract. Surv Ophthalmol.1995;39:323-334.
14. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related nuclear and cortical cataract: a case-control study in the Age-Related Eye Disease Study, AREDS Report No. 5. Ophthalmology.2001;108:1400- 1408.
15. Delcourt C, Carriere I, Ponton-Sanchez A, et al. Light exposure and the risk of cortical, nuclear, and posterior subcapsular cataracts: the Pathologies Oculaires Liees a l'Age (POLA) Study. Arch Ophthalmol.2000;118:385-392.
16. Rosmini F, Stazi MA, Milton RC, et al. A dose-response effect between a sunlight index and age-related cataracts: Italian-American Cataract Study Group. Ann Epidemiol.1994;4:266-270.
17. Taylor HR, West SK, Rosenthal FS, et al. Effect of ultraviolet radiation on cataract formation. N Engl J Med.1988;319:1429-1433.
18. Katoh N, Jonasson F, Sasaki H, et al. Cortical lens opacification in Iceland: risk factor analysis - Reykjavik Eye Study. Acta Ophthalmol Scand.2001;79:154-159.
19. Italian-American Cataract Study Group. Risk factors for age-related cortical, nuclear, and posterior subcapsular cataracts. Am J Epidemiol.1991;133:541-553.
20. Leske MC, Chylack LT Jr, Wu SY. The Lens Opacities Case-Control Study: risk factors for cataract. Arch Ophthalmol.1991;109:244-251.
21. Hiller R, Sperduto RD, Ederer F. Epidemiologic associations with nuclear, cortical and posterior subcapsular cataracts. Am J Epidemiol.1986;124:916-925.
22. Delcourt C, Cristol JP, Tessier F, et al. Risk factors for cortical, nuclear, and posterior subcapsular cataracts: the POLA Study. Am J Epidemiol.2000;151:497-504.
23. Carnahan MC, Goldstein DA. Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophthalmol.2000;11:478-483.
24. Valero MP, Fletcher AE, De Stavola BL, et al. Vitamin C is associated with reduced risk of cataract in a Mediterranean population. J Nutr.2002;132:1299-1306.
25. Kuzniarz M, Mitchell P, Cumming RG, Flood VM. Use of vitamin supplements and cataract: the Blue Mountains Eye Study. Am J Ophthalmol.2001;132:19-26.
26. Cumming RG, Mitchell P, Smith W. Diet and cataract. Ophthalmology. 2000;107:450-456.
27. Gale CR, Hall NF, Phillips DIW, Martyn CN. Plasma antioxidant vitamins and carotenoids and age-related cataract. Ophthalmology.2001;108:1992-1998.
28. Lyle BJ, Mares-Perlman JA, Klein BE, et al. Antioxidant intake and risk of incident age-related nuclear cataracts in the Beaver Dam Eye Study. Am J Epidemiol. 1999;149:801-809.
29. Lyle BJ, Mares-Perlman JA, Klein BE, et al. Serum carotenoids and tocopherols and incidence of age-related nuclear cataract. Am J Clin Nutr.1999;69:272-277.
30. Brown L, Rimm EB, Seddon JM, et al. A prospective study of carotenoid intake and risk of cataract extraction in US men.Am J Clin Nutr.1999;70:517-524.
31. Chasan-Taber L, Willett WC, Seddon JM, et al. A prospective study of carotenoid and vitamin A intakes and risk of cataract extraction in US women. Am J Clin Nutr. 1999;70:509-516.
32. Leske MC, Wu SY, Connell AMS, et al. Lens opacities, demographic factors and nutritional supplements in the Barbados Eye Study. Int J Epidemiol.1997;26:1314-1322.
33. Leske MC, Chylack LT Jr, He Q, et al. Antioxidant vitamins and nuclear opacities: the longitudinal study of cataract. Ophthalmology.1998;105:831-836.
34. McNeil JJ, Robman L, Tikellis G, et al. Vitamin E supplementation and cataract: randomized controlled trial. Ophthalmology.2004;111:75-84.
35. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS Report No. 9. Arch Ophthalmol.2001;119:1439-1452.
36. Livingston PM, Carson CA, Stanislavsky YL, et al. Methods for a population-based study of eye disease: the Melbourne Visual Impairment Project. Ophthalmic Epidemiol.1994;1:139-148.
37. Livingston PM, Lee SE, McCarty CA, Taylor HR. A comparison of participants with non-participants in a population-based epidemiologic study: the Melbourne Visual Impairment Project. Ophthalmic Epidemiol.1997;4:73-81.
38. McCarty CA, Mukesh BN, Dimitrov PN, Taylor HR. The incidence and progression of cataract in the Melbourne Visual Impairment Project. Am J Ophthalmol. 2003;136:10-17.
39. McCarty CA, De Paola C, Livingston PM, Taylor HR. Reliability of a food frequency questionnai re to assess dietary antioxidant intake. Ophthalmic Epidemiol. 1997;4:33-39.
40. McCarty CA, De Paola C, Livingston PM, Taylor HR. Ocular exposure to UV-B in sunlight: the Melbourne Visual Impairment Project. Bull World Health Organ.1996; 74:353-360.
41. Gritz DC. Can cataracts be prevented? Bull World Health Organ.2001;79:260-261.
42. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295-300.
43. Leske MC, Wu SY, Nemesure B, et al. Incidence and progression of lens opacities in the Barbados Eye Studies. Ophthalmology.2000;107:1267-1273.
44. Klein BEK, Klein R, Lee KE. Incidence of age-related cataract: the Beaver Dam Eye Study. Arch Ophthalmol.1998;116:219-225.
45. Leske MC, Connell AMS, Wu SY, et al. Prevalence of lens opacities in the Barbados Eye Study. Arch Ophthalmol.1997;115:105-111.
46. Klein BEK, Klein R, Linton KLP. Prevalence of age-related lens opacities in a population: the Beaver Dam Eye Study. Ophthalmology.1992;99:546-552.
47. Mitchell P, Cumming RG, Attebo K, Panchapakesan J. Prevalence of cataract in Australia: the Blue Mountains Eye Study. Ophthalmology.1997;104:581-588.
48. Worzala K, Hiller R, Sperduto RD, et al. Postmenopausal estrogen use, type of menopause, and lens opacities: the Framingham Studies. Arch Intern Med.2001;161:1448-1454.
49. Klein BEK, Klein R, Ritter LL. Is there evidence of an estrogen effect on age-related opacities? The Beaver Dam Eye Study. Arch Ophthalmol.1994;112:85- 91.
50. Cumming RG, Mitchell P. Hormone replacement therapy, reproductive factors, and cataract: the Blue Mountains Eye Study. Am J Epidemiol.1997;145: 242-249.
51. Minassian DC, Mehra V, Reidy A. Childbearing and risk of cataract in young women: an epidemiological study in central India. Br J Ophthalmol.2002;86:548-550.
52. West SK, Munoz B, Schein OD, et al. Racial differences in lens opacities: the Salisbury Eye Evaluation (SEE) Project. Am J Epidemiol.1998;148:1033-1039.
53. Hiller R, Sperduto RD, Podgor MJ, et al. Cigarette smoking and the risk of development of lens opacities: the Framingham studies. Arch Ophthalmol.1997;115:1113-1118.
54. Christen WG, Manson JE, Seddon JM, et al. A prospective study of cigarette smoking and risk of cataract in men. JAMA.1992;268:989-993.
55. Hankinson SE, Willett WC, Colditz GA, et al. A prospective study of cigarette smoking and risk of cataract in women. JAMA.1992;268:994-998.
56. West S, Munoz B, Emmett EA, Taylor HR. Cigarette smoking and risk of nuclear cataracts. Arch Ophthalmol.1989;107:1166-1169.
57. Hart WM Jr. Adler's Physiology of the Eye, Vol 10. 9th ed. St Louis, Mo: Mosby-Year Book; 1992:377-383.
58. Kleiman NJ, Spector A. DNA single strand breaks in human lens epithelial cells from patients with cataract. Curr Eye Res.1993;12:423-431.
59. Nicholl ID, Stitt AW, Moore JE, et al. Increased levels of advanced glycation end-products in the lenses and blood vessels of cigarette smokers. Mol Med.1998;4:594-601.
60. Leske MC, Chylack LT Jr, He Q, et al. Risk factors for nuclear opalescence in a longitudinal study: LSC Group, Longitudinal Study of Cataract. Am J Epidemiol. 1998;147:36-41.
61. Christen WG, Glynn RJ, Ajani UA, et al. Smoking cessation and risk of age-related cataract in men. JAMA.2000;284:713-716.
62. Weintraub JM, Willett WC, Rosner B, et al. Smoking cessation and cataract extraction among US women and men. Am J Epidemiol.2002;155:72-79.
63. Stitt AW. Advanced glycation: an important pathological event in diabetic and age-related ocular disease. Br J Ophthalmol.2001;85:746-753.
64. Schaumberg DA, Ridker PM, Glynn RJ, et al. High levels of plasma C-reactive protein and future risk of age-related cataract. Ann Epidemiol.1999;9:166-171.
65. Wang L, Bhatnagar A, Ansari NH, et al. Mechanisms of calcium-induced disintegrative globulization of rat lens fiber cells. Invest Ophthalmol Vis Sci.1996;37:915-922.
66. Bardak Y, Cekic O, Totan Y, Cengiz M. Effect of verapamil on lenticular calcium, magnesium and iron in radiation exposed rats. Int Ophthalmol.1998;22: 285-288.
67. Walsh SP, Patterson JW. Effects of hydrogen peroxide oxidation and calcium channel blockers on the equatorial potassium current of the frog lens. Exp Eye Res.1994;58:257-265.